Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.67K Buy
97
+78
+411% +$3.98K ﹤0.01% 682
2026
Q2
$996 Hold
19
– – ﹤0.01% 838
2026
Q1
$1.05K Hold
19
– – ﹤0.01% 808
2025
Q4
$932 Buy
+19
New +$886 ﹤0.01% 787
2025
Q3
– Sell
-45
Closed -$1.73K – 790
2025
Q2
$1.73K Sell
45
-499
-92% -$19.1K ﹤0.01% 655
2025
Q1
$21.1K Hold
544
– – ﹤0.01% 399
2024
Q4
$18.4K Hold
544
– – ﹤0.01% 407
2024
Q3
$22.2K Hold
544
– – ﹤0.01% 371
2024
Q2
$20.9K Hold
544
– – ﹤0.01% 389
2024
Q1
$23.3K Sell
544
-100
-16% -$4.12K ﹤0.01% 375
2023
Q4
$23.9K Buy
644
+100
+18% +$3.59K ﹤0.01% 368
2023
Q3
$19.7K Hold
544
– – ﹤0.01% 371
2023
Q2
$19.4K Sell
544
-20
-4% -$717 ﹤0.01% 393
2023
Q1
$20.1K Hold
564
– – ﹤0.01% 383
2022
Q4
$19.8K Hold
564
– – ﹤0.01% 378
2022
Q3
$17K Sell
564
-28
-5% -$1.06K ﹤0.01% 392
2022
Q2
$32K Buy
592
+32
+6% +$1.77K 0.01% 323
2022
Q1
$30K Buy
+560
New +$30.4K ﹤0.01% 336
2021
Q2
– Sell
-80
Closed -$4K – 713
2021
Q1
$4K Buy
+80
New +$3.63K ﹤0.01% 530
2020
Q3
– Sell
-14
Closed -$1K – 571
2020
Q2
$1K Buy
+14
New +$718 ﹤0.01% 504

Other funds holding GSK

Toth Financial Advisory's GSK Position: Q3 2026 in Review

Toth Financial Advisory increased its GSK (GSK) stake by 411% in Q3 2026, buying an estimated $3.98K and bringing the position to 97 shares worth $4.67K. The position accounts for ﹤0.01% of the portfolio, ranked #682.

Toth Financial Advisory first reported a position in GSK in Q2 2020 and has held it in 20 quarters since. The position peaked at $32K in Q2 2022. 31 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Toth Financial Advisory held 97 shares of GSK worth $4.67K as of Q3 2026.
  • Toth Financial Advisory bought 78 GSK shares in Q3 2026, an estimated $3.98K.
  • GSK made up ﹤0.01% of Toth Financial Advisory's portfolio in Q3 2026, its #682 holding.
  • Toth Financial Advisory first reported a position in GSK in Q2 2020 and has held it in 20 quarters since.
  • Toth Financial Advisory's GSK position peaked at $32K in Q2 2022.
  • 31 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.